Innoviva, Inc.
DE ˙ DB ˙ US45781M1018
19,20 € ↑0,70 (3,78%)
2026-06-04
DEL PRIS
SecurityDE:HVE / Innoviva, Inc.
InstitutionNorthern Trust Corp
Latest Disclosed Ownership774,303 shares
Latest Disclosed Value $ 18,041,261
Northern Trust Corp reports 10.92% increase in ownership of HVE / Innoviva, Inc.

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 774,303 shares of Innoviva, Inc. (DE:HVE) valued at $15,486,060 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 698,075 shares of Innoviva, Inc.. This represents a change in shares of 10.92% during the quarter. The current value of the position is $14,866,618 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F INNOVIVA COM 45781M101 774,303 76,228 10.92 18,041 29.29 0.0005
2026-02-17 2025-12-31 13F INNOVIVA COM 45781M101 698,075 -5,678 -0.81 13,955 8.65 0.0018
2025-11-14 2025-09-30 13F INNOVIVA COM 45781M101 703,753 9,248 1.33 12,843 -7.95 0.0016
2025-08-13 2025-06-30 13F INNOVIVA COM 45781M101 694,505 27,605 4.14 13,953 15.40 0.0019
2025-05-13 2025-03-31 13F INNOVIVA COM 45781M101 666,900 -12,144 -1.79 12,091 2.62 0.0018
2025-02-14 2024-12-31 13F INNOVIVA COM 45781M101 679,044 26,429 4.05 11,781 -6.51 0.0017
2024-11-13 2024-09-30 13F INNOVIVA COM 45781M101 652,615 1,036 0.16 12,602 17.93 0.0021
2024-08-14 2024-06-30 13F INNOVIVA COM 45781M101 651,579 -28,715 -4.22 10,686 3.07 0.0018
2024-05-14 2024-03-31 13F INNOVIVA COM 45781M101 680,294 525,714 340.09 10,368 1,556.07 0.0018
2024-02-13 2023-12-31 13F THESEUS PHARMACEUTICALS COM 88369M101 154,580 -2,745 -1.74 626 47.99 0.0001
2024-02-13 2023-12-31 13F INNOVIVA COM 45781M101 721,173 -2,555 11,568 0.0007
2023-11-13 2023-09-30 13F THESEUS PHARMACEUTICALS COM 88369M101 157,325 -6,790 -4.14 423 -72.37 0.0001
2023-11-13 2023-09-30 13F INNOVIVA COM 45781M101 723,728 -15,832 9,401 0.0018
2023-08-11 2023-06-30 13F THESEUS PHARMACEUTICALS COM 88369M101 164,115 30,655 22.97 1,531 29.20 0.0003
2023-08-11 2023-06-30 13F INNOVIVA COM 45781M101 739,560 -19,725 9,415 0.0018
2023-05-15 2023-03-31 13F THESEUS PHARMACEUTICALS COM 88369M101 133,460 159 0.12 1,185 78.73 0.0002
2023-05-15 2023-03-31 13F INNOVIVA COM 45781M101 759,285 -4,604 8,542 0.0006
2023-02-13 2022-12-31 13F THESEUS PHARMACEUTICALS COM 88369M101 133,301 -254 -0.19 664 -14.45 0.0001
2023-02-13 2022-12-31 13F INNOVIVA COM 45781M101 763,889 37,219 10,122 0.0021
2022-11-14 2022-09-30 13F THESEUS PHARMACEUTICALS COM 88369M101 133,555 5,495 4.29 775 9.46 0.0002
2022-11-14 2022-09-30 13F INNOVIVA COM 45781M101 726,670 -2,249 8,437 0.0019
2022-08-12 2022-06-30 13F THESEUS PHARMACEUTICALS COM 88369M101 128,060 30,921 31.83 708 -36.79 0.0002
2022-08-12 2022-06-30 13F INNOVIVA COM 45781M101 728,919 133,748 10,759 0.0023
2022-05-13 2022-03-31 13F THESEUS PHARMACEUTICALS COM 88369M101 97,139 255 0.26 1,120 -8.87 0.0002
2022-05-13 2022-03-31 13F INNOVIVA COM 45781M101 595,171 -20,866 11,516 0.0020
2022-02-08 2021-12-31 13F THESEUS PHARMACEUTICALS COM 88369M101 96,884 -537,792 -84.73 1,229 -88.41 0.0002
2022-02-08 2021-12-31 13F INNOVIVA COM 45781M101 616,037 -18,639 10,627 0.0017
2021-11-15 2021-09-30 13F INNOVIVA COM 45781M101 634,676 -148,879 -19.00 10,606 0.94 0.0019
2021-08-13 2021-06-30 13F INNOVIVA COM 45781M101 783,555 -25,529 -3.16 10,507 8.68 0.0019
2021-05-12 2021-03-31 13F INNOVIVA COM 45781M101 809,084 -56,667 -6.55 9,668 -9.86 0.0018
2021-02-11 2020-12-31 13F INNOVIVA COM 45781M101 865,751 -35,578 -3.95 10,726 13.88 0.0021
2020-11-16 2020-09-30 13F INNOVIVA COM 45781M101 901,329 -71,178 -7.32 9,419 -30.72 0.0021
2020-08-14 2020-06-30 13F INNOVIVA COM 45781M101 972,507 74,568 8.30 13,596 28.75 0.0032
2020-05-14 2020-03-31 13F INNOVIVA COM 45781M101 897,939 10,247 1.15 10,560 -16.00 0.0030
2020-02-14 2019-12-31 13F INNOVIVA COM 45781M101 887,692 -24,308 -2.67 12,571 30.78 0.0028
2019-11-13 2019-09-30 13F INNOVIVA COM 45781M101 912,000 -36,665 -3.86 9,612 -30.41 0.0023
2019-08-13 2019-06-30 13F INNOVIVA COM 45781M101 948,665 11,299 1.21 13,813 5.03 0.0033
2019-05-13 2019-03-31 13F INNOVIVA COM 45781M101 937,366 4,061 0.44 13,151 -19.25 0.0032
2019-02-12 2018-12-31 13F INNOVIVA COM 45781M101 933,305 -10,473 -1.11 16,286 13.22 0.0046
2018-11-14 2018-09-30 13F INNOVIVA COM 45781M101 943,778 -57,289 -5.72 14,384 4.12 0.0035
2018-09-18 2018-06-30 13F/A-1 INNOVIVA COM 45781M101 1,001,067 -32,070 -3.10 13,815 -19.79 0.0035
2018-08-14 2018-06-30 13F INNOVIVA COM 45781M101 1,007,865 -25,272 13,908
2018-05-09 2018-03-31 13F INNOVIVA COM 45781M101 1,033,137 -12,628 -1.21 17,223 16.07 0.0045
2018-02-14 2017-12-31 13F INNOVIVA COM 45781M101 1,045,765 -185,045 -15.03 14,839 -14.62 0.0038
2017-11-13 2017-09-30 13F INNOVIVA COM 45781M101 1,230,810 -12,236 -0.98 17,379 9.23 0.0045
2017-08-11 2017-06-30 13F INNOVIVA COM 45781M101 1,243,046 126,246 11.30 15,911 3.00 0.0044
2017-05-12 2017-03-31 13F INNOVIVA COM 45781M101 1,116,800 49,368 4.62 15,447 35.24 0.0045
2017-02-13 2016-12-31 13F INNOVIVA COM 45781M101 1,067,432 27,775 2.67 11,422 -0.04 0.0035
2016-11-09 2016-09-30 13F INNOVIVA COM 45781M101 1,039,657 8,167 0.79 11,426 5.19 0.0036
2016-08-12 2016-06-30 13F INNOVIVA COM 45781M101 1,031,490 -19,219 -1.83 10,862 -17.89 0.0035
2016-08-19 2016-03-31 13F/A-1 INNOVIVA COM 45781M101 1,050,709 147,944 16.39 13,228 39.02 0.0044
2016-05-13 2016-03-31 13F INNOVIVA COM 45781M101 1,050,709 13,228
2016-02-12 2015-12-31 13F THERAVANCE COM 88338T104 902,765 -110,652 -10.92 9,515 30.75 0.0032
2015-11-12 2015-09-30 13F THERAVANCE COM 88338T104 1,013,417 1,013,417 0.00 7,277 0.0024
2015-08-13 2015-06-30 13F THERAVANCE COM 88338T104 0 -906,130 -100.00 0 -100.00
2015-05-14 2015-03-31 13F THERAVANCE COM 88338T104 906,130 8,056 0.90 14,245 12.09 0.0043
2015-02-12 2014-12-31 13F THERAVANCE COM 88338T104 898,074 -33,980 -3.65 12,708 -20.22 0.0038
2014-11-13 2014-09-30 13F THERAVANCE COM 88338T104 932,054 520,770 126.62 15,928 30.05 0.0050
2014-08-14 2014-06-30 13F THERAVANCE COM 88338T104 411,284 75,886 22.63 12,248 18.02 0.0038
2014-05-14 2014-03-31 13F THERAVANCE COM 88338T104 335,398 -8,057 -2.35 10,378 -15.24 0.0033
2014-02-21 2013-12-31 13F/A-1 THERAVANCE COM 88338T104 343,455 29,817 9.51 12,244 -4.48 0.0039
2014-02-12 2013-12-31 13F THERAVANCE COM 88338T104 343,455 12,244
2013-11-13 2013-09-30 13F THERAVANCE COM 88338T104 313,638 -382,539 -54.95 12,818 -52.21 0.0045
2013-08-09 2013-06-30 13F THERAVANCE COM 88338T104 696,177 696,177 26,823 0.0097
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.